These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6761860)

  • 81. Combined treatment of severe intractable hypertension with captopril and diuretic.
    Atkinson AB; Brown JJ; Lever AF; Robertson JI
    Lancet; 1980 Jul; 2(8186):105-8. PubMed ID: 6105291
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Captopril - profile of a new antihypertensive (author's transl)].
    Gross F
    MMW Munch Med Wochenschr; 1981 Nov; 123(47):1803-9. PubMed ID: 6796855
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effects of captopril on the development of tolerance to guanethidine.
    Rankin GO; Haas GJ
    Fed Proc; 1984 Apr; 43(5):1342-5. PubMed ID: 6323227
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
    Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
    Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Long term effect of captopril in hypertension with chronic renal failure.
    Gassia JP; Durand D; Ton That H; Degroc F; Suc JM
    Proc Eur Dial Transplant Assoc; 1980; 17():719-24. PubMed ID: 7017704
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [The effect of angiotensin I converting enzyme inhibitor (SQ 14225) on arterial blood pressure].
    Watanabe H
    Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):405-19. PubMed ID: 6750185
    [No Abstract]   [Full Text] [Related]  

  • 88. Response of chronic renovascular hypertension to surgical correction or prolonged blockade of the renin-angiotensin system by two inhibitors in the rat.
    Thurston H; Bing RF; Marks ES; Swales JD
    Clin Sci (Lond); 1980 Jan; 58(1):15-20. PubMed ID: 6986225
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Angiotensin-converting enzyme inhibition in renal and hypertensive disorders.
    Götz R; Heidbreder E; Heidland A
    Clin Physiol Biochem; 1990; 8 Suppl 1():25-32. PubMed ID: 2257721
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Treatment of "therapy-resistant" forms of hypertension with captopril].
    Röckel A; Heidland A
    Med Klin; 1981 Jul; 76(15):427-33. PubMed ID: 7019656
    [No Abstract]   [Full Text] [Related]  

  • 91. Captopril affects blood pressure equally in renovascular and essential hypertension and in the fluid-depleted anephric state.
    de Bruyn JH; Wenting GJ; Man in 'T Veld AJ; Derkx FH; Schalekamp MA
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():83s-86s. PubMed ID: 7004742
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Review of the overall experience of captopril in hypertension.
    Frohlich ED; Cooper RA; Lewis EJ
    Arch Intern Med; 1984 Jul; 144(7):1441-4. PubMed ID: 6233948
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition.
    Bauer JH
    Am J Med; 1984 Aug; 77(2A):43-51. PubMed ID: 6206722
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Captopril: clinical pharmacology and benefit-to-risk ratio in hypertension and congestive heart failure.
    Vlasses PH; Ferguson RK; Chatterjee K
    Pharmacotherapy; 1982; 2(1):1-17. PubMed ID: 6765388
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery.
    Atkinson AB; Brown JJ; Davies DL; Leckie B; Lever AF; Morton JJ; Robertson JI
    Hypertension; 1981; 3(1):53-8. PubMed ID: 7009427
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Captopril and enalapril in the treatment of renal hypertension].
    Hasanagić H; Djukanović Lj; Subotić Z; Nesić V; Cavrić G
    Srp Arh Celok Lek; 1990; 118(7-8):285-90. PubMed ID: 2097777
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Captopril in diuretic-treated hypertensive patients.
    Koffer H; Vlasses PH; Ferguson RK; Weis M; Adler AG
    JAMA; 1980 Dec; 244(22):2532-5. PubMed ID: 7001071
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension.
    Campbell BC; Shepherd AN; Reid JL
    Br J Clin Pharmacol; 1982 Feb; 13(2):213-7. PubMed ID: 6277356
    [TBL] [Abstract][Full Text] [Related]  

  • 99. First dose effect of the oral angiotensin converting enzyme inhibitor captopril.
    Fagard R; Amery A; Lijnen P; Staessen J
    Arch Int Pharmacodyn Ther; 1980; Suppl():178-87. PubMed ID: 6251761
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension.
    Ideishi M; Sasaguri M; Ikeda M; Arakawa K
    Clin Ther; 1989; 11(4):441-51. PubMed ID: 2550133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.